Evaxion A (EVAX) Other Non-Current Liabilities (2021 - 2025)
Evaxion A (EVAX) posted Other Non-Current Liabilities of $158000.0 for Q4 2025, little changed on a QoQ basis from $158000.0 in Q2 2025, and up 12.06% year-over-year from $141000.0 in Q4 2024.
Evaxion A (EVAX) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends
Evaxion A's Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $158000.0 for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 12.06% year-over-year to $158000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $158000.0 (up 12.06% YoY) and the FY2025 annual result came in at $158000.0, up 12.06% from the prior year.
- Other Non-Current Liabilities was $158000.0 for Q4 2025 at Evaxion A, roughly flat from $158000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $573000.0 in Q4 2022 and bottomed at $52000.0 in Q1 2021.
- A 5-year average of $167461.5 and a median of $149000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 274.51% — and 2023, when it sank 74.0%.
- Evaxion A's Other Non-Current Liabilities stood at $153000.0 in 2021, then surged by 274.51% to $573000.0 in 2022, then sank by 74.0% to $149000.0 in 2023, then slipped by 5.37% to $141000.0 in 2024, then rose by 12.06% to $158000.0 in 2025.
- Business Quant data shows EVAX's Other Non-Current Liabilities at $158000.0 in Q4 2025, $158000.0 in Q2 2025, and $141000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 158,000.00 |
| Jun 30, 2025 | 158,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Dec 31, 2022 | 573,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | 53,000.00 |
| Mar 31, 2021 | 52,000.00 |